By Reuters Staff
1 Min Read
PARIS, Feb 1 (Reuters) - The AstraZeneca COVID-19 vaccine, which was approved by the European Commission last week, will start arriving in France next week at the latest, French European Affairs Minister Clement Beaune said on Monday.
“From the end of this week, latest early next week, AstraZeneca vaccine doses will start arriving in France .we will be able to start vaccinating (with it),” Beaune said on France Inter radio. (Reporting by GV De Clercq; editing by Jason Neely)
News24 com | Covid-19 wrap | Vaccines offered to onenewspage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onenewspage.com Daily Mail and Mail on Sunday newspapers.
PARIS (Reuters) - The AstraZeneca COVID-19 vaccine, which was approved by the European Commission last week, will start arriving in France next week a.
<div class="at-above-post addthis tool" data-url="https://www.metro.us/astrazeneca-vaccine-to-arrive/"></div>PARIS (Reuters) – The AstraZeneca COVID-19 vaccine, which was approved by the European Commission last week, will start arriving in France next week at the latest, French European Affairs Minister Clement Beaune said on Monday. “From the end of this week, latest early next week, AstraZeneca vaccine doses will start arriving in France… We will […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www.metro.us/astrazeneca-vaccine-to-arrive/&qu
EU ramps up pressure on AstraZeneca
EU Health Commissioner Stella Kyriakides said after the talks that the company s answers had not been satisfactory. The new schedule is not acceptable, she told DW. The EU prefinanced the development and production of vaccine against COVID-19 with a total of € 2.7 billion ($3.3 billion) and wants to see the return. Which doses have been produced, where and to whom have they been delivered? she said. The EU wants the prefinanced and preordered doses. The contract needs to be fully fulfilled.
The EU, Kyriakides added, is demanding transparency. In the future, all companies will have to provide early notification whenever they export a vaccine to a third country, she said. The remarks came in the wake of accusations that AstraZeneca is continuing to supply the UK while shortchanging the EU.